Cargando…
Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature
Deep brain stimulation is offered as symptomatic treatment in advanced Parkinson’s disease, depending on a clinical assessment of the individual patient’s risk-benefit profile. Genetics contribute to phenotypic variability in Parkinson’s disease, suggesting that genetic testing could have clinical r...
Autores principales: | Ligaard, Johanne, Sannæs, Julia, Pihlstrøm, Lasse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731254/ https://www.ncbi.nlm.nih.gov/pubmed/31508488 http://dx.doi.org/10.1038/s41531-019-0091-7 |
Ejemplares similares
-
Deep brain stimulation in Parkinson’s disease
por: Mehanna, Raja, et al.
Publicado: (2013) -
Deep brain stimulation for Parkinson's disease
por: Hariz, Marwan, et al.
Publicado: (2022) -
Global Variability in Deep Brain Stimulation Practices for Parkinson’s Disease
por: Mahajan, Abhimanyu, et al.
Publicado: (2021) -
Dissecting the limited genetic overlap of Parkinson's and Alzheimer's disease
por: Stolp Andersen, Maren, et al.
Publicado: (2022) -
Update on deep brain stimulation in Parkinson’s disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2015)